WD may accelerate and enhance inflammation, leading to obesity, metabolic disorders and gut microbiota dysbiosis, further disrupting the blood–brain barrier, causing central nervous system neuroinflammation, amyloid protein, and tau pathology, ultimately leading to a decline in cognitive function in humans (62). The gene discussed is MAPT; the disease is obesity due to melanocortin 4 receptor deficiency.